Elite Pharmaceuticals, Inc. (ELTP) Operating cash flow 2017–2026
Elite Pharmaceuticals, Inc. (ELTP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$23.7MFY2026 · since FY2017: -$7.9M → $23.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $23.7M | +218.5% |
| FY2025 | $7.5M | +330.5% |
| FY2024 | -$3.2M | -196.9% |
| FY2023 | $3.3M | -48.7% |
| FY2022 | $6.5M | +103.8% |
| FY2021 | $3.2M | +278.0% |
| FY2020 | -$1.8M | +73.6% |
| FY2019 | -$6.8M | -41.2% |
| FY2018 | -$4.8M | +39.0% |
| FY2017 | -$7.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice